Omer Butt

Company: CytoImmune Therapeutics

Job title: Vice President, Regulatory Affairs

Seminars:

Unraveling Regulatory Challenges in Transitioning from Pre-Clinical to Clinical Phases, Focusing on the IND Process 1:01 pm

Cell and gene therapies span pipelines across every phase of development, from preclinical stages through to approval. This presents an opportunity to learn from various phases and make regulatory processes more efficient. Join this session to: Hear case studies from companies overcoming challenges in transitioning between development stages to review and apply learnings to your…Read more

day: Pre-Conference Workshop Day